
Hassium Pharmaceuticals Private Limited
About Hassium Pharmaceuticals Private Limited
Data last updated:
Hassium Pharmaceuticals Private Limited is a private limited company based in Srinagar, Jammu And Kashmir, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 15 September 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Jammu, under CIN U74999JK2017PTC010118. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Peer Muzamil Ahmad and Sumeet Kaur.
Its last annual general meeting (AGM) was held on 28 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at Mehjoor Nagar Near Wanposh Hotel, Srinagar, Jammu and Kashmir, India – 190005.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Hassium Pharmaceuticals Private Limited's registered office is in Srinagar, Jammu And Kashmir. Its e-mail address is in the company report.
- Email
- Registered AddressMehjoor Nagar Near Wanposh Hotel, Srinagar, Jammu and Kashmir, India – 190005
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
To see the full contact details of Hassium Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Hassium Pharmaceuticals Private Limited
FY 2019 filings availableFinancial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Hassium Pharmaceuticals Private Limited, buy the company report.
Board of directors of Hassium Pharmaceuticals Private Limited
Hassium Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Peer Muzamil Ahmad | Director | 15 Sep 2017 | 9 Years 1 Months | Current |
| Sumeet Kaur | Director | 15 Sep 2017 | 9 Years 1 Months | Current |
| Kanwar Jeet Singh | Director | 15 Sep 2017 | 9 Years 1 Months | Current |
Legal cases
No court or tribunal cases involving Hassium Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hassium Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Hassium Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Hassium Pharmaceuticals Private Limited, buy the company report.
Recent activity
Hassium Pharmaceuticals Private Limited has 3 board changes on record since 2017: 3 appointments. The latest: Kanwar Jeet Singh was appointed as Director on 15 Sep 2017.
Frequently asked questions
Hassium Pharmaceuticals is an active private limited company based in Srinagar, Jammu And Kashmir, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 15 September 2017 (9+ years old) and is registered under CIN U74999JK2017PTC010118.
Hassium Pharmaceuticals has 3 current directors:
- Peer Muzamil Ahmad - Director
- Sumeet Kaur - Director
- Kanwar Jeet Singh - Director
The latest financial statements of Hassium Pharmaceuticals on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 28 September 2019. Year-wise statements from FY 2018 are in the company report.
No. Hassium Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Hassium Pharmaceuticals is U74999JK2017PTC010118. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hassium Pharmaceuticals was incorporated on 15 September 2017, making it 9+ years old. It is registered with the Registrar of Companies, Jammu.
Kanwar Jeet Singh was appointed as Director on 15 Sep 2017. Peer Muzamil Ahmad was appointed as Director on 15 Sep 2017. Sumeet Kaur was appointed as Director on 15 Sep 2017.
The registered office of Hassium Pharmaceuticals is at Mehjoor Nagar Near Wanposh Hotel, Srinagar, Jammu and Kashmir, India – 190005.
Hassium Pharmaceuticals operates in the business services industry, in the miscellaneous business activities segment.
The compliance status of Hassium Pharmaceuticals is compliant as of 12 August 2026. The company is actively filing with the Registrar of Companies.

